Literature DB >> 26115590

Moderate-severely bothersome vasomotor symptoms are associated with lowered psychological general wellbeing in women at midlife.

Pragya Gartoulla1, Robin J Bell1, Roisin Worsley1, Susan R Davis2.   

Abstract

OBJECTIVES: The extent to which menopause influences wellbeing is unclear. We investigated the association between moderate-severely bothersome vasomotor symptoms (VMS) and psychological general wellbeing in women, aged 40-65 years, taking into account socio-demographic and lifestyle factors. STUDY DESIGN/MAIN OUTCOME MEASURES: This was a cross-sectional survey of 2020 Australian women, aged 40-65 years, recruited from the community between July 2013 and March 2014. Wellbeing was assessed by the Psychological and General Wellbeing questionnaire (PGWB) and VMS by the Menopause-specific Quality of Life Questionnaire.
RESULTS: Moderate-severely bothersome VMS had a strong significant negative association with psychological general wellbeing [regression coefficient (β)=-8.17, 95% confidence interval (CI) -10.90 to -5.45]. Socio-demographic factors associated with lower wellbeing included being un-partnered (β=-2.80, 95% CI -4.74 to -0.86), obese (β=-5.46, 95% CI -7.24 to -3.68) and a smoker (β=-3.47, 95% CI -6.10 to -0.84). Older age (β=0.29, 95% CI 0.06-0.42) and participation in paid and/or volunteer work (β=2.72, 95% CI 0.61-4.82) were positively associated with wellbeing. For those with insecure housing, being a carer was associated with better wellbeing.
CONCLUSIONS: Moderate-severely bothersome VMS are significantly and independently negatively associated with psychological general wellbeing in women at midlife. This is an important consideration when assessing psychological wellbeing in women during this life phase.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Menopause; Psychological general wellbeing; Vasomotor symptoms

Mesh:

Year:  2015        PMID: 26115590     DOI: 10.1016/j.maturitas.2015.06.004

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  10 in total

Review 1.  Symptoms of menopause - global prevalence, physiology and implications.

Authors:  Patrizia Monteleone; Giulia Mascagni; Andrea Giannini; Andrea R Genazzani; Tommaso Simoncini
Journal:  Nat Rev Endocrinol       Date:  2018-02-02       Impact factor: 43.330

Review 2.  Treating menopause - MHT and beyond.

Authors:  Susan R Davis; Rodney J Baber
Journal:  Nat Rev Endocrinol       Date:  2022-05-27       Impact factor: 47.564

Review 3.  Investigation of the role of herbal medicine, acupressure, and acupuncture in the menopausal symptoms: An evidence-based systematic review study.

Authors:  Abed Ebrahimi; Naeimeh Tayebi; Ahmadinezhad Fatemeh; Marzieh Akbarzadeh
Journal:  J Family Med Prim Care       Date:  2020-06-30

Review 4.  The Efficacy and Safety of Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors in the Treatment of Menopausal Hot Flashes: A Systematic Review of Clinical Trials.

Authors:  Marzieh Azizi; Soghra Khani; Mahsa Kamali; Forouzan Elyasi
Journal:  Iran J Med Sci       Date:  2022-05

5.  The Relative Burden of Menopausal and Postmenopausal Symptoms versus Other Major Conditions: A Retrospective Analysis of the Medical Expenditure Panel Survey Data.

Authors:  Annlouise R Assaf; Andrew G Bushmakin; Nina Joyce; Michael J Louie; Michael Flores; Margaret Moffatt
Journal:  Am Health Drug Benefits       Date:  2017-09

Review 6.  Patient considerations in the management of menopausal symptoms: role of conjugated estrogens with bazedoxifene.

Authors:  Risa Kagan; Steven R Goldstein; James H Pickar; Barry S Komm
Journal:  Ther Clin Risk Manag       Date:  2016-04-07       Impact factor: 2.423

7.  Effects of a new combination of nutraceuticals on postmenopausal symptoms and metabolic profile: a crossover, randomized, double-blind trial.

Authors:  Valentina Trimarco; Francesco Rozza; Raffaele Izzo; Vincenzo De Leo; Valentina Cappelli; Carla Riccardi; Costantino Di Carlo
Journal:  Int J Womens Health       Date:  2016-10-11

8.  Risk Factors Linked to Psychological Distress, Productivity Losses, and Sick Leave in Low-Back-Pain Employees: A Three-Year Longitudinal Cohort Study.

Authors:  Angelo Compare; Paolo Marchettini; Cristina Zarbo
Journal:  Pain Res Treat       Date:  2016-08-18

9.  A survey of medical cannabis use during perimenopause and postmenopause.

Authors:  M Kathryn Dahlgren; Celine El-Abboud; Ashley M Lambros; Kelly A Sagar; Rosemary T Smith; Staci A Gruber
Journal:  Menopause       Date:  2022-08-02       Impact factor: 3.310

10.  Effect of the neurokinin 3 receptor antagonist fezolinetant on patient-reported outcomes in postmenopausal women with vasomotor symptoms: results of a randomized, placebo-controlled, double-blind, dose-ranging study (VESTA).

Authors:  Nanette Santoro; Arthur Waldbaum; Samuel Lederman; Robin Kroll; Graeme L Fraser; Christopher Lademacher; Laurence Skillern; James Young; Steven Ramael
Journal:  Menopause       Date:  2020-12       Impact factor: 3.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.